| AMPK and SIRT1: a long-standing partnership? NB Ruderman, X Julia Xu, L Nelson, JM Cacicedo, AK Saha, F Lan, Y Ido American Journal of Physiology-Endocrinology and Metabolism 298 (4), E751-E760, 2010 | 962 | 2010 |
| SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase X Hou, S Xu, KA Maitland-Toolan, K Sato, B Jiang, Y Ido, F Lan, K Walsh, ... Journal of Biological Chemistry 283 (29), 20015-20026, 2008 | 905 | 2008 |
| SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1: possible role in AMP-activated protein kinase activation F Lan, JM Cacicedo, N Ruderman, Y Ido Journal of Biological Chemistry 283 (41), 27628-27635, 2008 | 893 | 2008 |
| Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells J Zhou, W Huang, R Tao, S Ibaragi, F Lan, Y Ido, X Wu, YO Alekseyev, ... Oncogene 28 (18), 1993-2002, 2009 | 146 | 2009 |
| Acute Activation of AMP-Activated Protein Kinase Prevents H2O2-Induced Premature Senescence in Primary Human Keratinocytes Y Ido, A Duranton, F Lan, JM Cacicedo, TC Chen, L Breton, ... PloS one 7 (4), e35092, 2012 | 49 | 2012 |
| Post-translational modification of serine/threonine kinase LKB1 via adduction of the reactive lipid species 4-hydroxy-trans-2-nonenal (HNE) at lysine residue 97 directly … TD Calamaras, C Lee, F Lan, Y Ido, DA Siwik, WS Colucci Journal of Biological Chemistry 287 (50), 42400-42406, 2012 | 33 | 2012 |
| Activation of AMPKK-AMPK cascade by silence information regulator 2 (sir2) L Fan, JM Cacicedo, Y Ido Diabetes 54, A383, 2005 | 6 | 2005 |
| Sirt1 knockdown promotes senescence-like phenotype in 3T3L1 adipocyte, that is prevented by Sirt1-independent active LKB1 expression F Lan, JM Cacicedo, NB Ruderman, Y Ido Diabetes 59, A397-A398, 2010 | 2 | 2010 |
| Resveratrol Activates AMP-Activated Protein Kinase (AMPK) by Increasing LKB1 Activity and AMP/ATP Ratio. F Lan, V Schultz, JM Cacicedo, Y Ido Diabetes 56, 2007 | 1 | 2007 |
| Oxidant-mediated Post-translational Modifications of the LKB1 Protein in Mediating Cardiac Hypertrophy TD Calamaras, C Lee, F Lan, Y Ido, D Siwik, W Colucci Free Radical Biology and Medicine, S15-S16, 2010 | | 2010 |
| Compensatory Activation of AMP-Activated Protein Kinase Fails To Maintain Cellular ATP Levels in Sirt1 Deficient HepG2 Cells F Lan, J Cacicedo, Y Ido DIABETES 58, A21-A21, 2009 | | 2009 |
| Serum MIC-1 Concentrations Are Elevated in Patients with Type 2 Diabetes Mellitus D Cheng, Q Li, QF Cheng, F Lan, JM Cacicedo, Y Ido DIABETES 58, A618-A618, 2009 | | 2009 |
| SirT1 and resveratrol regulates LKB1 localization by deacetylation and phosphorylation Y Ido, F Lan, J Cacicedo DIABETES 57, A411-A411, 2008 | | 2008 |
| The Role of Sirt1 Activation of AMP-Activated Protein Kinase in the Effect of Polyphenols on Lipid Metabolism in HepG2 Cells Exposed to High Glucose. X Hou, S Xu, B Jiang, Y Ido, F Lan, M Wierzbicki, TJ Verbeuren, ... Diabetes 56, 2007 | | 2007 |
| AMP-activated protein kinase (AMPK) kinase LKB1 but not CamKK is regulated by silent information regulator 2 (Sir2) F Lan, JM Cacicedo, Y Ido DIABETES 55, A12-A13, 2006 | | 2006 |
| AMP-Activated Protein Kinase (AMPK) Is a Positive Regulator for Vascular Endothelial Growth Factor (VEGF)-Induced Vascular Cell Adhesion Molecule (VCAM)-1 Expression L Fan, JM Cacicedo, N Ruderman, Y Ido Diabetes 54, A193, 2005 | | 2005 |
